Entellus Medical (NASDAQ: ENTL) reported Q2 EPS of ($0.27), $0.08 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $18.7 million versus the consensus estimate of $18.48 million.

GUIDANCE:

Entellus Medical sees FY2016 revenue of $74-77 million, versus the consensus of $75.9 million.

For earnings history and earnings-related data on Entellus Medical (ENTL) click here.